 |
 |
|||||
 |
 |
 |
 |
 |
 |
|
Contact Information: Select Publications Levy DE , Meara ER. The effect of the 1998 Master Settlement Agreement on prenatal smoking. Journal of Health Economics, 2006; 25(2):276-294. Levy DE , O’Malley AJ, Normand ST. Estimating causal effects in the presence of treatment non-compliance, missing data, and continuous covariates. Statistics in Medicine 2004;23(15):2319-39. Vitale MG, Levy DE, Park MC, Choi H, Choe JC, Roye DP Jr. Quantifying risk of transfusion in children undergoing spine surgery. The Spine Journal 2002; 2(3):166-172. Vitale MG, Levy DE, Moskowitz AJ, Gelijns AC, Spellman M, Verdisco L, Roye DP. Capturing quality of life in pediatric orthopaedics: two recent measures compared. J Pediatric Orthopaedics 2001;21:629-635. Vitale MG, Levy DE, Johnson MG, Gelijns AC, Moskowitz AJ, Roye BD, Verdisco L, Roye DP. Assessment of quality of life in adolescent patients with orthopaedic problems: are adult measures appropriate? J Pediatric Orthopaedics 2001;21:622-628. Spratt TE, Schultz SS, Levy DE, Chen D, Schluter G, Williams GM. Different mechanisms for the photoinduced production of oxidative DNA damage by fluoroquinolones differing in photostability. Chem Res Toxicol 1999 Sep 20;12(9):809-815. |
Douglas E. Levy, PhD
Douglas E. Levy, PhD, is an Instructor in Medicine at Harvard Medical School and Assistant in Health Care Policy at the Institute for Health Policy at Massachusetts General Hospital. Dr. Levy received his doctoral degree in health policy from Harvard University where he held fellowships from the Agency for Healthcare Research and Quality (AHRQ) through a grant to Harvard University and the National Institute on Aging through a grant to the National Bureau of Economic Research.
Following his doctoral studies, Dr. Levy was an AHRQ post-doctoral fellow in health services research at the Harvard School of Public health. Dr. Levy also holds a Masters in Public Health from the Mailman School of Public Health at Columbia University and a Bachelor’s degree in chemistry (magna cum laude) from Amherst College.
Dr. Levy’s research addresses tobacco control policy, the effect of economic incentives on health behaviors, health, and health care spending, and the creation of simulation models for policy analysis. As part of the Harvard/MGH Center on Genomics, Vulnerable Populations and Health Disparities Dr. Levy will be leading an effort to examine how insurance coverage and financing of new genetic technologies will affect the diffusion and cost-effectiveness of these technologies, giving particular attention to how differences in access to genetic technologies will affect vulnerable populations.
